300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Belgium (May 2026)

The most active venture capital funds investing in Belgium Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Belgium Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Meusinvest (Noshaq)
VC Fund
8 Belgium, France, Germany Seed, Series A Health Care, Biotechnology, Medical $134k–$15M
Limburgse Reconversie Maatschappij
VC Fund
6 Belgium, United States, The Netherlands Series A, Seed Information Technology, Software, Biotechnology $482k–$11M
Capricorn Partners
VC Fund
5 Belgium, United States, The Netherlands Series B, Series A Biotechnology, Health Care, Software $1.6M–$41M
Newton Biocapital
VC Fund
5 Belgium, Japan, France Series A, Seed Biotechnology, Medical, Health Care
S.R.I.W.
VC Fund
4 Belgium, United States, Spain Series A, Series B Health Care, Biotechnology, Manufacturing $402k–$75M
V-Bio Ventures
VC Fund
4 Belgium, France, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Medical $3.6M–$86M
Qbic Fund
VC Fund
4 Belgium Seed, Series A Biotechnology, Software, Health Care $857k–$15M
Fund+
VC Fund
3 Belgium, United States, Spain Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $9.6M–$125M
WING by Digital Wallonia
VC Fund
3 Belgium Seed, Convertible Note, Series A Software, Health Care, Internet $214k–$11M
GoBeyond
VC Fund
3 Switzerland, Germany, United Kingdom Seed, Series A Information Technology, Medical, Software $533k–$10M
Gemma Frisius Fund
VC Fund
3 Belgium, France Seed, Series B, Series A Biotechnology, Health Care, Therapeutics $375k–$32M
Volta Ventures
VC Fund
3 Belgium, The Netherlands, Luxembourg Seed, Series A Software, Information Technology, Artificial Intelligence $482k–$7.5M
Inventures SA
VC Fund
2 Belgium, France, United Kingdom Series A, Seed Health Care, Manufacturing, Biotechnology $80k–$13M
White Fund
VC Fund
2 Belgium Seed, Series A, Series B Health Care, Medical, Medical Device
Buysse & Partners
VC Fund
2 Belgium, United Kingdom, The Netherlands Series A, Seed Software, Cloud Computing, FinTech $1.1M–$11M
Sambrinvest
VC Fund
2 Belgium, France, Spain Seed, Series A, Series B Biotechnology, Health Care, Information Technology $402k–$45M
Omnes Capital
VC Fund
2 France, United States, Belgium Series A, Series B Software, Biotechnology, Health Care $3.2M–$37M
PMV
VC Fund
2 Belgium, The Netherlands, United States Series A, Seed Software, Biotechnology, Health Care $500k–$26M
Be Angels
VC Fund
2 Belgium, France, Spain Seed, Pre-Seed Software, Information Technology, SaaS $78k–$903k
BAN Vlaanderen
VC Fund
2 Belgium Seed, Series A Health Care, Medical, Apps
Noshaq
VC Fund
2 Belgium Series A Medical, Analytics, Health Care
Spinventure
VC Fund
2 Belgium Series A Health Care, Biotechnology, Medical $750k–$15M
BioGeneration Ventures
VC Fund
2 The Netherlands, United States, United Kingdom Series A, Series B Biotechnology, Therapeutics, Health Care $4.5M–$60M
Thuja Capital
VC Fund
2 The Netherlands, Belgium, United States Series A, Seed Biotechnology, Medical, Health Care $1.4M–$32M
Ackermans & van Haaren
VC Fund
1 Belgium, India Series B, Series A, Series C Biotechnology, Health Care, Medical $3.1M–$52M
High-Tech Grunderfonds
VC Fund
1 Germany, Switzerland, United States Seed, Series A Software, Information Technology, Biotechnology $665k–$16M
Dental Innovation Alliance
VC Fund
1 Belgium, Germany, United States Seed, Series A Software, SaaS, Dental
SFPI-FPIM
VC Fund
1 Belgium, United States, France Series B, Series A Health Care, Biotechnology, Medical $4.3M–$125M
Ark Angels Activator Fund
VC Fund
1 Belgium Series A, Seed Software, Information Technology, SaaS $911k–$7.5M
Earlybird Venture Capital
VC Fund
1 Germany, United States, United Kingdom Series A, Seed, Series B Software, Information Technology, Health Care $1.2M–$40M
Limburg Startup
VC Fund
1 The Netherlands, France, Belgium Series A, Series B Biotechnology, Medical, Health Care $1.9M–$5.4M
The CoFoundry
VC Fund
1 Belgium, The Netherlands, United States Seed, Series A Software, Network Security, SaaS $857k–$2.1M
Allegro Investment Fund
VC Fund
1 Belgium, United States, The Netherlands Series A, Series B Software, Hardware, Apps $1.9M–$19M
Mérieux Equity Partners
VC Fund
1 France, Sweden, Belgium Series A, Private Equity Biotechnology, Medical, Health Care $10M–$18M
Quest for Growth
VC Fund
1 Belgium, France, The Netherlands Series B, Series C Biotechnology, Software, Hardware $510k–$21M
Financière Spin-Off Luxembourgeoise
VC Fund
1 Belgium Series A Medical, Health Care, Medical Device
Sofinnova Investments
VC Fund
1 United States, France, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $7.3M–$73M
EQT life science
VC Fund
1 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $5.4M–$70M
Flanders Future Techfund
VC Fund
1 Belgium Seed Medical, Semiconductor, Clinical Trials
Gimv
VC Fund
1 Belgium, United States, France Series B, Private Equity Biotechnology, Health Care, Medical $6M–$80M
BIP Investment Partners
VC Fund
1 Belgium Series A, Series B Video, Medical, Software
New Rhein
VC Fund
1 United States, Israel, Belgium Series A, Series B, Seed Medical, Biotechnology, Health Care $7M–$21M
LeanSquare
VC Fund
1 Belgium, France, United States Seed, Series A Software, Music, Internet $200k–$11M
NV Industriebank LIOF
VC Fund
1 The Netherlands, Belgium Series A, Seed Biotechnology, Medical, Health Care $482k–$2.1M
BNP Paribas Fortis
VC Fund
1 Belgium, United States, Germany Debt Financing, Series B Biotechnology, Logistics, Software $9.6M–$2B
Yonjin Venture
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $3.4M–$29M
Delta Partners
VC Fund
1 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $777k–$6.4M
Vinnof
VC Fund
1 Belgium, United Kingdom Series A, Series B Biotechnology, Health Care, Medical $9.1M–$11M
CPH Banque
VC Fund
1 Belgium Series B Health Care, Medical, Training
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $4.5M–$115M
Access all 116 VC funds in Belgium Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 8 investments in Belgium Medical startups, 10 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 54
  • Round size: Seed $134k–$4M; Series A $1.1M–$15M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Limburgse Reconversie Maatschappij
VC Fund · Hasselt, Limburg, Belgium · 6 investments in Belgium Medical startups

Oxygen for growth - LRM

Show more...

Investment focus

  • Industry: Information Technology, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 81
  • Round size: Seed $482k–$2.7M; Series A $1.6M–$11M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Qviro — Compare industrial robotics and brands based on user ratings, product prices, use-cases. Reviews for Collaborative robots, Cobots, Industrial robots
  • Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
  • MobieTrain — The mobile microlearning platform of Mobietrain improves knowledge retention with personalised, gamified learning to boost your sales.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 5 investments in Belgium Medical startups, 7 in the past 12 months

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 98
  • Round size: Series A $1.6M–$11M; Series B $4.5M–$41M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $93M in 2019

Portfolio highlights

  • Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show all investments...

Newton Biocapital
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 5 investments in Belgium Medical startups

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, Japan, France

Investor stats

  • Total investments: 17
  • Lead/follow: 71% lead, 29% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • AdipoPharma — By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

S.R.I.W.
VC Fund · Liège, Liege, Belgium · 4 investments in Belgium Medical startups

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 109
  • Round size: Series A $402k–$30M; Series B $1.6M–$75M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

V-Bio Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 4 investments in Belgium Medical startups

Achieving global impact in effective healthcare & sustainable agriculture by helping talented entrepreneurs / scientist set up exceptional companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Belgium, France, United Kingdom

Investor stats

  • Total investments: 28
  • Round size: Seed $3.6M–$32M; Series A $6.4M–$45M; Series B $19M–$86M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $118M in 2021

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
Show all investments...

Qbic Fund
VC Fund · Belgium, Wisconsin, United States · 4 investments in Belgium Medical startups

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 37
  • Round size: Seed $1.3M–$5.4M; Series A $857k–$15M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • Morrow Optics — Looking for the next big thing in eyewear technology? Check out Morrow's electrified progressives, also known as autofocals! These innovative glasses switch focus length with a touch of button, providing you with seamless vision from near to far. Learn more about this technology on Morrow's website.
  • Swave Photonics — Our mission is to bring the metaverse to life and enable display manufacturers and content creators to disrupt the visualization market with immersive, ultra-high-resolution, lifelike, true holographic displays.
Show all investments...

Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in Belgium Medical startups

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 25
  • Round size: Series A $9.6M–$45M; Series B $20M–$125M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • eTheRNA immunotherapies — eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

WING by Digital Wallonia
VC Fund · Liège, Liege, Belgium · 3 investments in Belgium Medical startups

W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).

Show more...

Investment focus

  • Industry: Software, Health Care, Internet
  • Stage:Seed, Convertible Note, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 30
  • Round size: Seed $268k–$1.3M; Series A $1.1M–$11M; Convertible Note $214k–$562k
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
  • MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
  • Verbolia — The SEO game-changer for e-commerce, helping retailers reclaim top organic search rankings. Discover untapped long-tail keywords from your product catalog and auto-generate SEO optimized pages at scale.
Show all investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland · 3 investments in Belgium Medical startups

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Industry: Information Technology, Medical, Software
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 161
  • Round size: Seed $533k–$5M; Series A $1.1M–$10M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
  • AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
  • Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Gemma Frisius Fund
VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in Belgium Medical startups

Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series B, Series A
  • Geography: Belgium, France

Investor stats

  • Total investments: 29
  • Round size: Seed $375k–$32M; Series A $911k–$16M; Series B $4.3M–$19M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • DName-iT — DName-iT is a genetic analysis tool that offers DNA-based barcode labeling technology and a software platform that can ensure reliable, cost-effective NGS specimen identification.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Show all investments...

Volta Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 3 investments in Belgium Medical startups, 8 in the past 12 months

Volta Ventures is a venture capital firm, offering seed & early stage VC for internet & software companies (SaaS) in the Benelux region

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Belgium, The Netherlands, Luxembourg

Investor stats

  • Total investments: 68
  • Round size: Seed $482k–$5.2M; Series A $1.6M–$7.5M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Next Gate Tech — Next Gate Tech is a Luxembourg based, data-driven FundTech that provides innovative Software-as-a-Service solutions for the asset management industry. Our mission is to enhance the Fund industry technology, thanks to machine learning, data analytics, and smart automation. We capitalize on the rapid emergence of cloud-based computing frameworks tooffer fast, accurate, and robust solutions to our clients. We provide intelligent, adaptive, and dynamic automation solutions through a web platform to help industry players manage middle and back-office processes.
  • Propellant.digital — We are a Netherlands based FinTech that is focused on bring together public and private data to power business decisions in a low cost way. Born in 2021, our mission is to organise financial markets information and make it transparent, accessible, affordable and useful to all parties in the ecosystem. Propellant.Digital is headed up by foundersVincent Grandjean, and Allan Horgan, both professionals who have a long history in the financial market technology sector and wanted to leverage their experience to create a solution that was low cost.
  • Ecochain Technologies — Ecochain is a life cycle assessment software and services company that helps companies reduce their environmental footprint. Learn more.
Show all investments...

Inventures SA
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Medical startups

Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Series A, Seed
  • Geography: Belgium, France, United Kingdom

Investor stats

  • Total investments: 44
  • Round size: Seed $80k–$2M; Series A $402k–$13M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
  • myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
  • Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Show all investments...

White Fund
VC Fund · 2 investments in Belgium Medical startups

For game changers in medtech

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2019

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show all investments...

Buysse & Partners
VC Fund · Antwerpen, Antwerpen, Belgium · 2 investments in Belgium Medical startups

Buysse and Partners is a private equity investment group based in Antwerpen that offers smart equity, a growth fund, and partnerships.

Show more...

Investment focus

  • Industry: Software, Cloud Computing, FinTech
  • Stage:Series A, Seed
  • Geography: Belgium, United Kingdom, The Netherlands

Investor stats

  • Total investments: 6
  • Round size: Seed $1.1M–$1.9M; Series A $3.9M–$11M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2012

Portfolio highlights

  • Twikit — Twikit is an enterprise software company with a sharp focus on mass customization and digital manufacturing. We set new standards on how brands and enterprises conceptualize and manufacture products: customizable, on demand and digitally manufactured. The company has its HQ in Antwerp - Belgium and commercial offices in New York City and Stuttgart.The core differentiator of Twikit is the combined knowledge of software, product engineering for digital manufacturing and digital business chains. We work with our partners across the world to enable advanced product individualization by offering seamless end-to-end solutions from ideation to full integration with our enterprise software solutions. Our unique strength is that we integrate product parametrization and UX with digital manufacturing and mass customization at scale into any (existing) business and digital manufacturing flow.
  • Bluebee — Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
  • moonbird — HealthTech, Mindfulness, Hardware, Better breathing
Show all investments...

Sambrinvest
VC Fund · Gosselies, Hainaut, Belgium · 2 investments in Belgium Medical startups

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, France, Spain

Investor stats

  • Total investments: 30
  • Round size: Seed $531k–$903k; Series A $402k–$45M; Series B $11M–$23M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • cikisi — Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 2 investments in Belgium Medical startups, 9 in the past 12 months

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 152
  • Round size: Series A $3.2M–$21M; Series B $4M–$37M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $407M in 2020

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • The Exploration Company — For Space & Non-Space Industries.
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Medical startups, 7 in the past 12 months

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, The Netherlands, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $500k–$4.2M; Series A $2.1M–$26M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • IVEX — At IVEX, we are creating a safety co-pilot to make existing decision making platforms for autonomous driving safe. Our technology is based on years of research performed at KU Leuven University in Belgium. Our unique IP and team experience in behavior planning and functional safety enables the development of safe and reliable autonomous systems toreduce the traffic victims to zero by 2030.
  • Funkey — Kies je teambuilding uit meer dan 500 onvergetelijke activiteiten. Wij zorgen voor de volledige organisatie, incl. eventuele catering en overnachting.
  • dScribe — dScribe is your one-stop-shop to catalog, document and discover anything data-related.No more spending hours looking for the right data.No more doubting about the meaning of your KPIs.Reach the next level of data maturity by offering your users a single entry point to find, understand and access all your reports & data, no matter wherethey are stored.
Show all investments...

Be Angels
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 2 investments in Belgium Medical startups

Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors. The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Belgium, France, Spain

Investor stats

  • Total investments: 20
  • Round size: Seed $241k–$903k; Pre-Seed $78k–$364k
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
  • DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
  • HeartKinetics — Heart failure diagnosis. HeartKinetics is a digital company dedicated to the remote detection and monitoring of patients with heart failure.
Show all investments...

BAN Vlaanderen
VC Fund · Hasselt, Limburg, Belgium · 2 investments in Belgium Medical startups

BAN Vlaanderen is the business angel network in Flanders, a value-added platform within which new or growing businesses are brought into contact with informal private investors, called Business Angels. Looking for venture capital This Business Angels bring not only money but also their own know-how, experience and contacts. Are connecting servicesoffered. Both the entrepreneurs and the business angelsBAN Vlaanderen is no investment, it does not own shares or take any investment decisions, nor for its own account or on behalf of the affiliates. Instead, it is a market where supply and demand are brought together. The information on this site is intended to initiate the purpose and operation of BAN Vlaanderen. For more information you can always contact one of our regional offices.BAN Vlaanderen is an association that aims to stimulate the development, support and promotion of entrepreneurship and investment culture in Belgium. Economic growth in Belgium

Show more...

Investment focus

  • Industry: Health Care, Medical, Apps
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • TheraSolve — TheraSolve NV is a medical technology company dedicated to developing and commercializing innovative, user-friendly, and cost-effective solutions to promoting medication adherence. TheraSolve’s patented technology platform will motivate broad patient populations to take their medications as prescribed, and more generally, to perform anyhealth-promoting activity in a timely fashion.
  • Pom — POM stands for Peace of Mind. And it's exactly that worry-free feeling that they want their customers to achieve through their invoice management solutions, both for the receiver and the sender.Their goal is to eliminate the senseless time and effort spent because of inefficient systems. And thus freeing up time to do the things that reallymatter.
  • Oncomfort — Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Noshaq
VC Fund · Liège, Liege, Belgium · 2 investments in Belgium Medical startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Medical, Analytics, Health Care
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • DeuterOncology — DeuterOncology is a preclinical-stage biotech company focusing on the development of a first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show all investments...

Spinventure
VC Fund · Angleur, Liege, Belgium · 2 investments in Belgium Medical startups

Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Round size: Series A $750k–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
  • Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
  • Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Show all investments...

BioGeneration Ventures
VC Fund · Naarden, Noord-Holland, The Netherlands · 2 investments in Belgium Medical startups

Shaping new life-science ventures.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Series B
  • Geography: The Netherlands, United States, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Series A $4.5M–$60M; Series B $6.4M–$54M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2021

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Dualyx — Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Show all investments...

Thuja Capital
VC Fund · Utrecht, Utrecht, The Netherlands · 2 investments in Belgium Medical startups

Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: The Netherlands, Belgium, United States

Investor stats

  • Total investments: 49
  • Round size: Seed $1.4M–$32M; Series A $3.5M–$9.1M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • FundaMental Pharma — Use this space to add a brief description of your project.
Show all investments...

Ackermans & van Haaren
VC Fund · Antwerpen, Antwerpen, Belgium · 1 investments in Belgium Medical startups

Ackermans & van Haaren is a diversified group active in 5 segments: Marine Engineering & Infrastructure; Private Banking; Real Estate, Leisure & Senior Care; Energy & Resources; Development Capital. Marine Engineering & Infrastructure: DEME, one of the largest dredging companies in the world - Algemene Aannemingen Van Laere,a leading contractor in Belgium. Ackermans & van Haaren is an independent and diversified group aiming at creating shareholder value through long-term investments in a limited number of companies with growth potential on an international level.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: Belgium, India

Investor stats

  • Total investments: 10
  • Round size: Series A $8.3M–$15M; Series B $3.1M–$41M; Series C $38M–$52M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Medikabazaar — Medikabazaar is an online B2B marketspace for medical supplies and equipment. They are a single point of contact for all product-based needs, enabling medical institutions and individual practitioners alike to cut down on operational costs and making the best global brands available locally, all aided with the miracle that goes by the name oftechnology. They are connected with more than 50,000 medical establishments, 1,50,000 Independent Practitioners, and have partnered with 13,000+ suppliers all over India including ones in Tier 2, Tier 3 cities, and remoter locations to establish a strong foothold in India and simultaneously earn the respect of our clients. With the power of technology, we organized a haywire market in a country with perhaps the largest and most complex geographical structure in the world for this purpose. Our last-mile delivery system and 26 strategically placed Fulfilment Centres across India enable us to deliver essential medical supplies to healthcare facilities and help them nurture quality and timely patient care. With our first international office in the Middle East, we are transcending boundaries to deliver care, everywhere.
  • Indigo Diabetes — Revolutionizing the management of chronic disease.
Show all investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 1 investments in Belgium Medical startups, 64 in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 373
  • Round size: Seed $665k–$5.1M; Series A $1.5M–$16M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show all investments...

Dental Innovation Alliance
VC Fund · Raleigh, North Carolina, United States · 1 investments in Belgium Medical startups

Dental Innovation Alliance (DIA) is a venture capital company that invests in, advises on, and accelerates the growth of early-stage companies that are transforming dentistry through technology.

Show more...

Investment focus

  • Industry: Software, SaaS, Dental
  • Stage:Seed, Series A
  • Geography: Belgium, Germany, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Relu — Integrate Relu's automatic 3D segmentations seamlessly into your CBCT software.
  • UptimeHealth — UptimeHealth, headquartered in Boston, MA, is a fast-growing software startup that simplifies medical device service events, purchases, and compliance practices through automation and predictive analytics.
  • Dentognostics GmbH — Dentognostics is a reasearch based firm that offers medicine and dentistry innovative and powerful systems for diagnostics, and therapy.
Show all investments...

SFPI-FPIM
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Medical startups

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A
  • Geography: Belgium, United States, France

Investor stats

  • Total investments: 36
  • Round size: Series A $4.3M–$45M; Series B $11M–$125M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Cohabs — Cohabs is a network of beautiful shared homes for nomads around the world. It provides flexible and fully furnished accommodations through a network of sustainable and community-driven shared homes. Cohabs prioritizes the experience of its members through a tech-centric and flexible process. They build a thriving community through monthly events,dinners, and other parties.
  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Show all investments...

Ark Angels Activator Fund
VC Fund · Hasselt, Limburg, Belgium · 1 investments in Belgium Medical startups

Ark Angels Activator Fund SA is a closed venture capital fund (closed-end private equity investment fund) with a capital of 14.8 M EUR. The Fund is recognized as ARKIV and has obtained the status of Private Privak under Belgian law. The Fund is managed by a management company set up by BAN Vlaanderen VZW, ING Belgium & the two fund managers.The Fund initially acted primarily as a co-investor in investments made by business angels who are members of BAN Vlaanderen, but then also co-invested with other capital providers. It focuses not only on investments in young growth companies, but also on companies in the growth or transfer phase with an operating office in Flanders,

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Series A, Seed
  • Geography: Belgium

Investor stats

  • Total investments: 20
  • Round size: Seed $911k–$1.6M; Series A $1.2M–$7.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Apicbase — Apicbase is a F&B management platform that gives you total visibility of your back of house so you can grow without compromise.
  • waylay — Waylay is a leading Enterprise IT-OT digital unification software company delivering low-code based orchestration, automation and analytics software solutions. Waylay has a passion for supporting enterprises on their IoT automation journey and ensuring it puts all valuable data to work for developers, data scientists and domain experts.
  • Accelleran — Accelleran is pioneering a disruptive approach to the delivery of cost-effective, carrier and mission-critical grade TDD and FDD Small Cell networks through its focus on software quality and partnerships with volume manufacturers.Accelleran provides LTE Small Cell software and LTE Small Cell product solutions which address the real-worldchallenges of volume deployment of Small Cells. We offer turnkey solutions and unique experience on the challenges of integrating cellular technology on low cost, yet powerful platforms and architectures. Accelleran offers its customers solid and dependable system solutions, backed by the support of our unparalleled expertise.Accelleran’s technology is genuinely independent from any HW platform and enables operators to invest once in the integration and validation of a common software base that can be deployed across different segments, platforms and Small Cell architectural approaches to enable a truly integrated HetNet.
Show all investments...

Earlybird Venture Capital
VC Fund · Berlin, Berlin, Germany · 1 investments in Belgium Medical startups, 23 in the past 12 months

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 247
  • Round size: Seed $1.2M–$14M; Series A $2M–$26M; Series B $4.8M–$40M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Binalyze — Binalyze enhances all your digital forensics and incident response processes at max speed.
  • ColibrITD — Quantum Computing Software Algorithm
  • Re-Fresh Global — Re-Fresh Global brings sustainability innovation into the manufacturing industry. Our patented biotechnology transforms textile waste into recycled raw materials: nanocellulose, ethanol, and sanitized textile pulp.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Limburg Startup
VC Fund · Maastricht, Limburg, The Netherlands · 1 investments in Belgium Medical startups

Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: The Netherlands, France, Belgium

Investor stats

  • Total investments: 11
  • Round size: Series A $2.1M–$3.2M; Series B $1.9M–$5.4M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Ekompany — Ekompany is a Dutch producer of coated mineral fertilisers (CRF) with sales operations in Western Europe and Far East. Their team of professionals possesses the latest knowledge across the chemical, agricultural and horticultural fields and have decades of experience in designing, producing and supplying specialty fertilisers supported by the rightadvice.Established in 2010, their unique production facility in Born was opened for production in September 2013. Ekompany has developed a patented coating process that is clean, safe, continuous and more energy efficient than existing ones. This way they can produce intelligent Controlled Release Fertilisers that are both technologically advanced and economical for wider use in agriculture and horticulture. Learn more about their Ekote portfolio which has proven its benefits in more than 200 field trials internationally.
  • FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
  • Kriya Materials — Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces.
Show all investments...

The CoFoundry
VC Fund · Antwerp, Antwerpen, Belgium · 1 investments in Belgium Medical startups

The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.

Show more...

Investment focus

  • Industry: Software, Network Security, SaaS
  • Stage:Seed, Series A
  • Geography: Belgium, The Netherlands, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $857k–$2.1M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
Show all investments...

Allegro Investment Fund
VC Fund · Heverlee, Vlaams-Brabant, Belgium · 1 investments in Belgium Medical startups

Allegro Investment Fund is an open end seed capital investment fund, focussing on high-tech ventures. With a combined experience of more then 40 years of experience in high-tech start-up management, the AIF team adds smart money to your capital needs.

Show more...

Investment focus

  • Industry: Software, Hardware, Apps
  • Stage:Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 9
  • Round size: Series A $1.9M–$3.3M; Series B $10M–$19M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Visys — Visys NV, The optical sorting innovation Company, is a leading state-of-the-art provider of Digital automated sorting solutions to the global food and non-food processing industry.
  • Mass Relevance — Mass Relevance develops and offers cloud-based software for media and entertainment sectors.Its software enables social media content aggregation, filtration, and integration. The company's clientele includes December, 2010. The company was founded in 2009 and is based in Austin, Texas.In April 2014, Mass Relevance merged with Spredfast, forming a comprehensive social marketing company.
  • GreenPeak Technologies — GreenPeak Technologies operates as a fabless semiconductor and is one of the leaders in the ZigBee market with a rich offering of RF chips for the Smart Home and the IoT.Driven by the world’s MSOs, GreenPeak is proving its market leadership position as the Internet of Things connectivity technology provider for the Smart Home.GreenPeakTechnologies is a fabless semiconductor company and the leader in the ZigBee market with a rich offering of semiconductor products and software technologies for Smart Home data communications and the Internet of Things.The GreenPeak founders have significantly contributed to the invention of WiFi and made it into a commercial success, used by several billion people today. GreenPeak is recognised as a leader in developing new wireless technologies for consumer electronics, Smart Home applications and the IoT/IoE, demonstrating rapid growth and adoption by major customers around the globe.It offers its products for original equipment manufacturers in the United States, Europe, and Asia. The company was formerly known as Xanadu Wireless and changed its name to GreenPeak Technologies B.V. in 2007. GreenPeak Technologies was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, Japan, France, California, US as well as in Korea and Hong Kong.
Show all investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 1 investments in Belgium Medical startups

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Private Equity
  • Geography: France, Sweden, Belgium

Investor stats

  • Total investments: 11
  • Round size: Series A $10M–$18M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — raised $404M in 2020

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
  • Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.
Show all investments...

Quest for Growth
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Belgium Medical startups

Quest for Growth (QGPLF) is an Internet company located in 19 Lei, Leuven, Flanders, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Hardware
  • Stage:Series B, Series C
  • Geography: Belgium, France, The Netherlands

Investor stats

  • Total investments: 22
  • Round size: Series B $510k–$20M; Series C $8.1M–$21M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Finquest — Finquest is the premier deal origination provider delivering personalized connections to its clients who seek M&A and direct investment opportunities in Europe, North America, and APAC.With a unique database, machine learning and a team of experts, Finquest provides targeted, curated and actionable connections, whilst maintaining completeconfidentiality throughout the process. With Finquest, clients can broaden their market access, creating a more efficient deal-making environment.Finquest is headquartered in Singapore and has offices in New York, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • EclecticIQ — EclecticIQ is a global threat intelligence, hunting and response technology provider. Its clients are some of the most targeted organizations, globally. To build tomorrow’s defenses today, they have to understand the threats against them – and align their efforts and investments to mitigate their risks. EclecticIQ helps governments, largeenterprises and service providers manage threat intelligence, create situational awareness and adopt an intelligence-led cybersecurity approach. EclecticIQ extended its focus towards hunting and response with the acquisition of Polylogyx’s endpoint technology in 2020. Founded in 2014, EclecticIQ operates globally with offices across Europe, North America, and via value-add partners. More info: www.eclecticiq.com
Show all investments...

Financière Spin-Off Luxembourgeoise
VC Fund · 1 investments in Belgium Medical startups

Specializes in spin-off and spin-out investments.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
Show all investments...

Sofinnova Investments
VC Fund · Menlo Park, California, United States · 1 investments in Belgium Medical startups, 6 in the past 12 months

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 190
  • Round size: Series A $7.3M–$50M; Series B $12M–$73M; Series C $12M–$60M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • Alkeus Pharmaceuticals — Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Show all investments...

EQT life science
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Belgium Medical startups, 6 in the past 12 months

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 132
  • Round size: Series A $6.4M–$50M; Series B $5.4M–$69M; Series C $10M–$70M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $279M in 2023

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Show all investments...

Flanders Future Techfund
VC Fund · 1 investments in Belgium Medical startups

Flanders Future Techfund operates as an investment firm.

Show more...

Investment focus

  • Industry: Medical, Semiconductor, Clinical Trials
  • Stage:Seed
  • Geography: Belgium

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Swave Photonics — Our mission is to bring the metaverse to life and enable display manufacturers and content creators to disrupt the visualization market with immersive, ultra-high-resolution, lifelike, true holographic displays.
Show all investments...

Gimv
VC Fund · Antwerpen, Antwerpen, Belgium · 1 investments in Belgium Medical startups

Gimv is a European investment company with over three decades of experience in private equity and venture capital.Gimv is listed on NYSE Euronext Brussels. Gimv currently manages around 1.8 billion EUR (including third party funds) of investments in 85 portfolio companies, which jointly realise a turnover of more than EUR 6 billion and employover 28,000 professionals.As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Consumer 2020, Health & Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts.More information on Gimv can be found on [www.gimv.com].

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: Belgium, United States, France

Investor stats

  • Total investments: 150
  • Round size: Series B $6M–$46M; Private Equity $7.5M–$80M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $653M in 2010

Portfolio highlights

  • ERS — ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
BIP Investment Partners
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Belgium Medical startups

BIP Investment Partners S.A. (BIP) is an independent financial holding company backed by Luxembourg family shareholders.Its activities are divided between providing private equity to businesses, particularly venture capital to startups, and investing in large, well-established Luxembourg-based businessesThe company was founded in 2000 as ajoint venture between Banque Générale du Luxembourg (BGL), later a part of Fortis Group, and now as the newly re-formed BGL and several smaller partners, under the name BGL Investment Partners, which was changed to 'BIP Investment Partners' in February 2006 after the rebranding of BGL. BIP is listed on the Luxembourg Stock Exchange, where it is one of the ten component companies of the main LuxX Index stock market index.

Show more...

Investment focus

  • Industry: Video, Medical, Software
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • XDC — CinemaNext is the largest cinema integrator company in EMEA (installation, digital, content, Dolby Atmos, laser projectors, NOC, maintenance & support).
  • Movetis — I found a great domain name for sale on Dan.com. Check it out!
Show all investments...

New Rhein
VC Fund · 1 investments in Belgium Medical startups

New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, Belgium

Investor stats

  • Total investments: 9
  • Round size: Series B $7M–$21M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
  • Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
Show all investments...

LeanSquare
VC Fund · Liège, Liege, Belgium · 1 investments in Belgium Medical startups

New Economy Startups Investor & Accelerator

Show more...

Investment focus

  • Industry: Software, Music, Internet
  • Stage:Seed, Series A
  • Geography: Belgium, France, United States

Investor stats

  • Total investments: 31
  • Round size: Seed $200k–$1.4M; Series A $242k–$11M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Zapfloor — Zapfloor is the number one workspace management software for coworking spaces, serviced offices and corporate workspaces in Europe.
  • ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
  • Streamforge — Streamforge is the technology-first, turnkey solution for all of your influencer marketing needs.
Show all investments...

NV Industriebank LIOF
VC Fund · Maastricht, Limburg, The Netherlands · 1 investments in Belgium Medical startups

NV Industriebank LIOF is the Limburg development and investment company. LIOF contributes to the prosperity of the province with an ongoing program to strengthen the province's economic base. LIOF targets industry and the dynamic service sector.Its four core activities are Acquisition, Participation, Development/Innovation andBusiness Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development/implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.LIOF has a strategic approach which targets opportunities for long-term economic development. In this it has a bridging role between government and business. LIOF is an ambitious professional organization and speaks the language that business understands.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: The Netherlands, Belgium

Investor stats

  • Total investments: 18
  • Round size: Seed $482k–$536k; Series A $2.1M–$2.1M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Embrosa — Embrosa specializes in delivering marketing content from the brand's HQ to local retailers across the globe.
  • Neuroplast — Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
  • Aerial Precision — Experience the most streamlined and user-friendly workflow, seamlessly transforming iPad LiDAR data processing into exceptional deliverables.
Show all investments...

BNP Paribas Fortis
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Medical startups

BNP Paribas Fortis is a bank that provides personal and business banking services.

Show more...

Investment focus

  • Industry: Biotechnology, Logistics, Software
  • Stage:Debt Financing, Series B
  • Geography: Belgium, United States, Germany

Investor stats

  • Total investments: 19
  • Round size: Series B $9.6M–$17M; Debt Financing $100M–$2B
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Aircastle — Aircastle is a global company that acquires, leases and sells high-utility commercial jet aircraft to customers throughout the world. High-utility aircraft are generally modern, operationally efficient jets with a large operator base and long useful lives. As of December 31, 2013, Aircastle's aircraft portfolio consisted of 162 aircraft onlease with 64 customers located in 37 countries. From time to time, we also make investments in other aviation assets, including debt securities secured by commercial jet aircraft.Their business is managed by a team of aviation professionals with extensive industry experience. Through servicing offices in the US, Ireland and Singapore, they provide their airline customers with an exceptional level of service and their investors with global coverage and local market knowledge. Aircastle employs a balanced approach to investment and capitalization, factoring in industry cyclicality and other global and regional market dynamics. They focus on a long-term investment horizon. Their diversified fleet includes Boeing and Airbus narrow and mid-body aircraft including both passenger and freighter applications. Their professionals have extensive experience with aircraft finance, leasing and investment management.
  • MobieTrain — The mobile microlearning platform of Mobietrain improves knowledge retention with personalised, gamified learning to boost your sales.
  • Global Infrastructure Partners (GIP) — A leading global, independent infrastructure fund manager.
Show all investments...

Yonjin Venture
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Belgium Medical startups

Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.It focuses on the innovative technologies in therapeutics, diagnostics, and medical devices. The firm is a sub-organization of Yongjin Group and the sister firm of Yonghua Capital.The Cambridge, Massachusetts-based firm was establishedin 2018.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 18
  • Round size: Series A $3.4M–$29M; Series B $9.3M–$13M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
  • Bluejay Therapeutics — At Bluejay, we are discovering life-changing medicines and cures for people with viral and liver diseases, starting with chronic hepatitis B (CHB) and chronic hepatitis D (CHD).
Show all investments...

Delta Partners
VC Fund · Leopardstown, Dublin, Ireland · 1 investments in Belgium Medical startups

Early stage VC investments and funding for start-ups / founders in Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 96
  • Round size: Seed $777k–$2.7M; Series A $1.6M–$6.4M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Kayna — Kayna is an insurance distribution company that collaborates with vertical SaaS platforms and utilises data to offer insurance services.
  • Tailr — Redefining production for the clothing industry.
  • Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Show all investments...

Vinnof
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Medical startups

Vinnof is a venture capital firm that offers seed capital to innovative, early-stage startups based in Flanders, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Belgium, United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Series A $9.1M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Apitope — Worg Pharmaceuticals has acquired all of the assets of Apitope International NV. You will be automatically redirected to www.worgpharma.com in ? seconds or click the link now. Worg Pharmaceuticals (Hangzhou) Co., Ltd.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • Okapi Sciences — Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination ofindividuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises.
Show all investments...

CPH Banque
VC Fund · Tournai, Basse-Normandie, France · 1 investments in Belgium Medical startups

CPH Banque is a financial services company that provides loan, head full projects and mobile banking services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Training
  • Stage:Series B
  • Geography: Belgium

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • OncoDNA — OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.
  • I-care Group — I-care offers products, training, and services to its industrial customers.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Belgium Medical startups, 8 in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 118
  • Round size: Series A $4.5M–$30M; Series B $12M–$115M; Series C $5.6M–$65M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Mariana Oncology — Mariana Oncology is a biotechnology research industry.
  • Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show all investments...

Medical VC funding in Belgium at a glance

Stats across 87 deals from 116 investors.

116
investors
in Belgium Medical startups
87
deals
in Belgium Medical startups
$5.1M
median round
in Belgium Medical startups
41%
lead investors
lead at least one round
25%
Series A
most common funding stage

Access all 116 VC funds in Belgium Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 116 VC funds investing in Belgium Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists